These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 35781422)
21. Neurological Manifestations of COVID-19 in Children: Time to Be More Vigilant. Madaan P; Singanamalla B; Saini L Pediatr Neurol; 2021 Feb; 115():28. PubMed ID: 33316688 [No Abstract] [Full Text] [Related]
27. Catastrophic Neurological Complications in 2 Patients With Sickle Cell Disease and COVID-19. Clarke K; Benameur K; Wiley Z; Shin YM; Moussa M; El Rassi F; McLemore M J Investig Med High Impact Case Rep; 2022; 10():23247096221111778. PubMed ID: 35850596 [TBL] [Abstract][Full Text] [Related]
28. Neurological issues during COVID-19: An overview. Nath A; Smith B Neurosci Lett; 2021 Jan; 742():135533. PubMed ID: 33248163 [TBL] [Abstract][Full Text] [Related]
30. A wide spectrum of neurological manifestations in pediatrics patients with the COVID-19 infection: a case series. Krueger MB; Montenegro RC; de Araújo Coimbra PP; de Queiroz Lemos L; Fiorenza RM; da Silva Fernandes CJ; Pessoa MSL; Rodrigues CL; da Cruz CG; de Araújo Verdiano V; de Carvalho Araújo FM; Braga-Neto P; Sobreira-Neto MA J Neurovirol; 2021 Oct; 27(5):782-786. PubMed ID: 34448147 [TBL] [Abstract][Full Text] [Related]
31. Acute central and peripheral nervous system injury associated with coronavirus disease 2019: recognition and treatment strategies. Simon DW; Schober ME Curr Opin Pediatr; 2021 Dec; 33(6):591-596. PubMed ID: 34670263 [TBL] [Abstract][Full Text] [Related]
32. Neurologic aspects of coronavirus disease of 2019 infection. Hassett CE; Frontera JA Curr Opin Infect Dis; 2021 Jun; 34(3):217-227. PubMed ID: 33769966 [TBL] [Abstract][Full Text] [Related]
34. Neuro-COVID-19 is more than anosmia: clinical presentation, neurodiagnostics, therapies, and prognosis. Schweitzer F; Kleineberg NN; Göreci Y; Onur OA; Franke C; Warnke C Curr Opin Neurol; 2021 Jun; 34(3):423-431. PubMed ID: 33709973 [TBL] [Abstract][Full Text] [Related]
35. Letter to the Editor: "What Are the Long-Term Neurological and Neuropsychiatric Consequences of COVID-19?". Pan Y; Zhao S; Chen F World Neurosurg; 2020 Dec; 144():310-311. PubMed ID: 33227857 [No Abstract] [Full Text] [Related]
36. Miller-Fisher syndrome after COVID-19: neurochemical markers as an early sign of nervous system involvement. Senel M; Abu-Rumeileh S; Michel D; Garibashvili T; Althaus K; Kassubek J; Otto M Eur J Neurol; 2020 Nov; 27(11):2378-2380. PubMed ID: 32781484 [TBL] [Abstract][Full Text] [Related]
37. Spectrum of neuroimaging findings in COVID-19. El Beltagi AH; Vattoth S; Abdelhady M; Ahmed I; Paksoy Y; Abou Kamar M; Alsoub H; Almaslamani M; Alkhal AL; Own A; Elsotouhy A Br J Radiol; 2021 Jan; 94(1117):20200812. PubMed ID: 33305996 [TBL] [Abstract][Full Text] [Related]
39. Long-term Health Consequences of COVID-19. Del Rio C; Collins LF; Malani P JAMA; 2020 Nov; 324(17):1723-1724. PubMed ID: 33031513 [No Abstract] [Full Text] [Related]
40. Neurological issues in children with COVID-19. Lin JE; Asfour A; Sewell TB; Hooe B; Pryce P; Earley C; Shen MY; Kerner-Rossi M; Thakur KT; Vargas WS; Silver WG; Geneslaw AS Neurosci Lett; 2021 Jan; 743():135567. PubMed ID: 33352286 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]